Deferoxamine photosensitizes cancer cells in vitro

Biochemical and Biophysical Research Communications

Volumn 332, Issue 2, 2005, Pages 388-391

  Juzenas, Petras ^a   Juzeniene, Asta ^a   Moan, Johan ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Endogenous porphyrins; Ferrochelatase; Heme biosynthesis; Phototoxicity

Indexed keywords

DEFEROXAMINE; PHOTOSENSITIZING AGENT; PORPHYRIN;

ADENOCARCINOMA; ARTICLE; CANCER CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERYTHROID CELL; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LIGHT EXPOSURE; PHOTODYNAMICS; PHOTOSENSITIZATION; PRIORITY JOURNAL;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; DEFEROXAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IRON CHELATING AGENTS; LEUKEMIA, MYELOID, CHRONIC; LIGHT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 19444377591     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.138     Document Type: Article

References (21)

1. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng Photodynamic therapy J. Natl. Cancer Inst. 90 1998 889 905
2. D.E. Dolmans, D. Fukumura, and R.K. Jain Photodynamic therapy for cancer Nat. Rev. Cancer 3 2003 380 387
3. J.C. Kennedy, and R.H. Pottier Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy J. Photochem. Photobiol. B: Biol. 14 1992 275 292
4. Q. Peng, K. Berg, J. Moan, M. Kongshaug, and J.M. Nesland 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research Photochem. Photobiol. 65 1997 235 251
5. K. Berg, H. Anholt, O. Bech, and J. Moan The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolevulinic acid-treated cells Br. J. Cancer 74 1996 688 697
6. G.J. Kontoghiorghes, K. Pattichi, M. Hadjigavriel, and A. Kolnagou Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1) Transfus. Sci. 23 2000 211 223
7. D.R. Richardson, and P. Ponka Development of iron chelators to treat iron overload disease and their use as experimental tools to probe intracellular iron metabolism Am. J. Hematol. 58 1998 299 305
8. R.M. Bannerman, S.T. Callender, and D.L. Williams Effect of desferrioxamine and D.T.P.A. in iron overload Br. Med. J. II 1962 1573 1577
9. H. Keberle The biochemistry of desferrioxamine and its relation to iron metabolism Ann. N.Y. Acad. Sci. 119 1964 758 775
10. Z. Malik, G. Kostenich, L. Roitman, B. Ehrenberg, and A. Orenstein Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice J. Photochem. Photobiol. B: Biol. 28 1995 213 218
11. B. Ortel, A. Tanew, and H. Honigsmann Lethal photosensitization by endogenous porphyrins of PAM cells-modification by desferrioxamine J. Photochem. Photobiol. B: Biol. 17 1993 273 278
12. P. Noguchi, R. Wallace, J. Johnson, E.M. Earley, S. O'Brien, S. Ferrone, M.A. Pellegrino, J. Milstien, C. Needy, W. Browne, and J. Petricciani Characterization of the WIDR: a human colon carcinoma cell line In Vitro 15 1979 401 408
13. J. Okabe-Kado, M. Hayashi, Y. Honma, M. Hozumi, and T. Tsuruo Effects of inducers of erythroid differentiation of human leukemia K562 cells on vincristine-resistant K562/VCR cells Leuk. Res. 7 1983 481 485
14. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
15. J.L. Merlin, S. Azzi, D. Lignon, C. Ramacci, N. Zeghari, and F. Guillemin MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy Eur. J. Cancer A 28 1992 1452 1458
16. I.U. Pardoe, K.K. Grewal, M.P. Baldeh, J. Hamid, and A.T. Burness Persistent infection of K562 cells by encephalomyocarditis virus J. Virol. 64 1990 6040 6044
17. C.J. Gomer, J.V. Jester, N.J. Razum, B.C. Szirth, and A.L. Murphree Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue Cancer Res. 45 1985 3718 3725
18. W.C. Tan, N. Krasner, P. O'Toole, and M. Lombard Enhancement of photodynamic therapy in gastric cancer cells by removal of iron Gut 41 1997 14 18 (Comment in: Gut 1998, 42(5), 759-760)
19. J. Moan, and S. Sommer Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells Cancer Res. 45 1985 1608 1610
20. M. Ochsner Photophysical and photobiological processes in the photodynamic therapy of tumours J. Photochem. Photobiol. B: Biol. 39 1997 1 18
21. M.C. DeRosa, and R.J. Crutchley Photosensitized singlet oxygen and its applications Coordin. Chem. Rev. 233-234 2002 351 371